In Vitro Diagnostics Market is expected to grow at a CAGR of 4.6% during the forecasted period | Evolve Business Intelligence

As per the study initiated by Evolve Business Intelligence, the global In Vitro Diagnostics Market size accounted for USD 92.5 billion in 2022, growing at a CAGR of 4.6% from 2023 to 2033. The In Vitro Diagnostics (IVD) market involves the use of medical devices, reagents, and instruments for diagnosing diseases or conditions outside the human body. It encompasses a wide range of tests conducted on biological samples such as blood, urine, and tissue, providing critical information for medical decision-making. Key segments include clinical chemistry, immunoassays, molecular diagnostics, and point-of-care testing. The market is driven by the increasing prevalence of chronic diseases, technological advancements, and a growing aging population. Regulatory approvals, adherence to quality standards, and collaborations with healthcare providers are crucial factors influencing the competitive landscape of the IVD market.
Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021369
The In Vitro Diagnostics (IVD) market is primarily driven by the rising incidence of chronic diseases, increasing demand for personalized medicine, and advancements in diagnostic technologies. Additionally, the growing geriatric population and the emphasis on early disease detection contribute to the market's expansion. Regulatory support for innovative diagnostic solutions further propels the IVD market's growth.
Key Players
Some of the major In Vitro Diagnostics Market players holding high market shares include Exact Sciences Corporation, Invitae Corporation, NeoGenomics Laboratories and Natera, Inc. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., InterVenn Biosciences, Freenome Holdings, Inc., Agilent Technologies, Inc., Guardant Health, Illumina, Inc.
Report Description: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021369
Segmental Analysis
Based on product & services, the In Vitro Diagnostics market is segmented into reagents & kits, instruments, and software & services. Due to the ongoing need for diagnostic testing solutions, the creation of novel and specialized reagents, and the rise in the prevalence of diseases requiring precise diagnostic procedures, the reagents and kits segment led the in vitro diagnostics market in terms of size in 2022 and is predicted to hold this position throughout the forecast period.
Based on technique, the In Vitro Diagnostics market is segmented into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and others. The IVD market size was led by the immunodiagnostics sector in 2022, and this trend is expected to persist during the forecast period. Its high throughput, low cost, high sensitivity analysis, and intrinsic specificity in the examination of biological materials are credited with this.
Based on application, the In Vitro Diagnostics market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. Due to the rise in infectious disorders that require diagnostic testing, such as hepatitis and HIV, the infectious diseases segment held the biggest share of the in vitro diagnostics market in 2022 and is predicted to maintain this position during the forecast period.
Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.

This release was published on openPR.